Berend M E, Sullivan D C, Kornguth P J, Skinner C S, Ost A, Iglehart J D, Skinner M A
Duke University School of Medicine, Durham, NC.
Arch Surg. 1992 Nov;127(11):1309-13. doi: 10.1001/archsurg.1992.01420110055012.
The purpose of this investigation was to determine the natural history and risk of malignancy associated with isolated indeterminate microcalcifications subjected to interval follow-up. During a 2-year study, 91 patients were identified with indeterminate microcalcifications alone. Specific roentgenographic features of the calcifications were evaluated on initial and follow-up mammograms. During a mean follow-up of 36 months, 19 (21%) of the women exhibited mammographic changes. Ten patients (11%) with suspicious changes underwent a needle-directed biopsy 6 to 30 months after the initial mammographic screening. Five women (5.5%) were diagnosed as having breast carcinoma; three had invasive ductal carcinoma and two had purely intraductal lesions. Four patients had axillary lymph node dissections and no metastatic disease was found. We found no significant differences in the roentgenographic features associated with malignant vs benign lesions apart from an increased overall estimation of the probability of malignancy rating in the five patients with breast carcinoma. We recommend that patients be followed up with mammography at regular intervals for at least 18 months following recognition of indeterminate microcalcifications.
本研究的目的是确定接受定期随访的孤立性不确定微小钙化灶的自然病程及恶变风险。在一项为期2年的研究中,共确定了91例仅伴有不确定微小钙化灶的患者。在初次及随访乳腺钼靶片上评估钙化灶的具体影像学特征。在平均36个月的随访期间,19名(21%)女性出现了乳腺钼靶改变。10名(11%)有可疑改变的患者在初次乳腺钼靶筛查后6至30个月接受了针吸活检。5名女性(5.5%)被诊断为患有乳腺癌;3例为浸润性导管癌,2例为单纯导管内病变。4例患者接受了腋窝淋巴结清扫,未发现转移病灶。除了对5例乳腺癌患者的恶变概率评估总体有所增加外,我们发现恶性病变与良性病变相关的影像学特征无显著差异。我们建议,在发现不确定微小钙化灶后,患者应定期进行乳腺钼靶检查,至少随访18个月。